SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that Medicare reimbursement for CorMedixs DefenCath could fall sharply in 2027 has fueled a steep selloff and concern about future pricing and sales. Traders dispute how conclusive DaVitas estimate is, pointing to CMSs finalized payment rate and arguing the outlook depends on quarterly calculations and DefenCath uptake.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA approval of Inovios competing RRP treatment has put Precigens PAPZIMEOS under scrutiny, with traders debating whether the new option will erode its market position. Some fear stronger competition, while others point to Precigens first-mover and full-approval advantages and question Inovios ability to commercialize its drug.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, supported by Eylea HD and Dupixent-related collaboration revenue, are driving a sharp breakout to multiyear highs. Traders are broadly bullish on the results and follow-through, while some question whether the gains will hold.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is drawing attention after Brazil approved its Valaris merger, which traders see as a step toward closing the deal, alongside recent offshore contract wins and higher day-rate expectations. Bulls anticipate improved scale and a potential short squeeze, while skeptics point to merger-related dilution, debt and the upcoming earnings report.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys integration with Metas Muse AI agent, which can route purchases through Shop Pay, has fueled discussion about whether agentic commerce will expand Shopifys role in online shopping or threaten traditional storefronts. Traders are also debating the stocks sharp, volatile pullback, with some looking ahead to earnings and others concerned about valuation and whether AI-related growth will translate into revenue.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,942,077.7905448. The last known price of Zcash is 1,263.32437248 USD and is up 2.82 over the last 24 hours. It is currently trading on 668 active market(s) with $1,115,981,976.30 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp rebound and resilience amid broader crypto weakness and Binance hack fears have traders highlighting its privacy features and speculating about a safe-haven shift into ZEC; some also point to the upcoming NU7 upgrade. Others view the rally as overextended and expect further declines.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected quarterly report and higher full-year revenue outlook, powered by demand for Mounjaro and Zepbound, have fueled LLYs rally and record highs. Traders are largely positive and cite analyst upgrades, while some question the valuation and point to trimmed profit guidance tied to acquisition-related research charges.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A rally to a fresh 52-week high ahead of an expected quarterly report has traders focused on BRIUMVI growth and whether results can justify the run; some expect an earnings-driven move, while others warn the stock may be priced for a beat. Buyout speculation and possible short covering are also fueling bullish chatter, but no deal is confirmed and the earnings timing remains uncertain.

BankrCoin (BNKR) is a cryptocurrency and operates on the Base platform. BankrCoin has a current supply of 100,000,000,000 with 99,389,999,999.99966667 in circulation. The last known price of BankrCoin is 0.00029512 USD and is up 9.48 over the last 24 hours. It is currently trading on 84 active market(s) with $2,292,823.67 traded over the last 24 hours. More information can be found at https://warpcast.com/bankr.

BankrCoin

Traders are focused on Bankrs expanding AI-agent infrastructure and ecosystem integrations, alongside claims of protocol revenue, staking rewards and token buybacks that could support BNKR demand. Sentiment is largely bullish and accumulation-oriented, though some traders question whether the sharp moves are sustainable or speculative.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons quarterly results beat expectations, with record refining performance benefiting from tight diesel supplies amid geopolitical disruptions. Traders are broadly positive on the refining-led strength and shareholder returns, while some question whether the unusually strong margins can last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ingram Micro (INGM) Q3 Earnings and Revenues Top Estimates

Ingram Micro (INGM) delivered earnings and revenue surprises of +16.67% and +10.06%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Cricut Gears Up to Report Q3 Earnings: What's in the Cards?

CRCT is set to report Q3'26 earnings as shares rise 30.5% in three months. AI-driven growth supports revenues despite margin pressures & the 70% EPS decline.

Analysts Estimate QXO, Inc. (QXO) to Report a Decline in Earnings: What to Look Out for

QXO INC (QXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Aptiv Gears Up to Report Q3 Earnings: What's in the Cards?

APTV's Q3 2026 earnings & revenues are expected to decline sharply amid its business spin-off and rising costs, despite ADAS growth and new partnerships.

Dave Inc. (DAVE) Reports Next Week: Wall Street Expects Earnings Growth

DAVE INC (DAVE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Dave Inc. (DAVE) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Nu Holdings vs. Dave: Which Fintech Stock Is the Better Buy Right Now?

NU and DAVE offer contrasting fintech growth stories, with differences in scale, profitability, valuation and stock performance shaping the investment debate.

Wall Street Analysts Think DAVE INC (DAVE) Could Surge 36.61%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in DAVE INC (DAVE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Will DAVE INC (DAVE) Beat Estimates Again in Its Next Earnings Report?

DAVE INC (DAVE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

SEZL vs. DAVE: Which Consumer Fintech Stock Is the Better Bet?

Sezzle and Dave scale digital finance through different growth engines, with product breadth, credit trends and monetization shaping the fintech face-off.

This account has been verified as an official DAVE representative.

Verified Account

Dave Inc

Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.

Dave Inc - Ordinary Shares - Class A

Opendoor Bull Eric Jackson Says DAVE Stock Could Replicate Sezzle's 47x Run — And Wall Street Is Missing A Major Catalyst

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Jackson believes ‘Pay-In-4’ would add $25 million to $117 million to Dave’s revenue by 2028.</li><li>Jackson, known for his bullish bet in Opendoor, has previously backed Palantir, Carvana, Better Home &amp; Finance, IREN, and BTQ Technologies.</li><li>DAVE shares have declined by over 16% year-to-date; Stocktwits sentiment for the ticker was ‘bullish.’</li></ul>Hedge fund manager Eric Jackson, best known for backing the meme stock Opendoor, published a thesis on Sunday arguing&nbsp;for a strong upside in fintech player Dave, Inc.&nbsp;In a Substack&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://eventhorizoniq.substack.com/p/dave-at-186-pay-in-four-could-add?r=1iiu0&amp;utm_campaign=post&amp;utm_medium=web&amp;triedRedirect=true">blog</a> and accompanying&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/ericjackson/status/2043312237939446032">X thread</a>, Jackson said that the market is overlooking a major upcoming catalyst in Dave: the launch of "Pay in Four," which could add between $25 million and $117 million in incremental annual revenue by 2028 and push its stock higher&nbsp;by several multiples.Sezzle, Inc. “went from $4 to $187 doing exactly what DAVE is about to do. Wall Street is modeling zero revenue from it,” he said on his X thread, comparing the buy-now-pay-later (BNPL) lender’s stock’s&nbsp;47-times growth between January 2024 and July 2025.&nbsp;“Even after Hindenburg shorted it and it crashed 68%, shareholders who bought at $4 are still sitting on a 15-bagger.”<h2 class="st-heading-2">‘Pay-In-4’</h2>Dave is a U.S.-based fintech platform offering products such as small-dollar cash advances (ExtraCash), digital banking, budgeting tools, and a subscription model. It uses AI-driven underwriting (CashAI) to assess credit risk and expand lending. The company went public by merging with a special purpose acquisition firm (SPAC) in January 2022.Recently, Dave has seen strong growth – revenue surged about 60% in 2025 with profitability improving sharply – and is rolling out new products. The company is testing “Pay in 4,” a BNPL option that lets customers split a purchase into four equal, interest-free installments, typically paid every two weeks and allows shoppers to spread out payments without using a credit card, with a full-scale rollout expected later this year.<h2 class="st-heading-2">Dave Could Replicate Sezzle’s Growth</h2>Dave is following a successful growth playbook similar to Sezzle (SEZL), but with a superior, more stable business model, Jackson argued. Because Dave already possesses a massive proprietary dataset on its subprime customer base and operates with high-profit leverage, the new revenue engine from Pay in 4 would drive massive growth in net income and lead to a significant long-term stock re-rating.“When you add a product to an existing customer base with no incremental CAC, most of that revenue drops to the bottom line,” Jackson said, highlighting Dave’s lean 200 to 300-member team and 3 million customers.“DAVE already trades at 10.6x forward earnings -- cheaper than Sezzle at 12.7x... At $186, you are getting this optionality [Pay in Four] for free,” he said.<h2 class="st-heading-2">Jackson’s Other Bets</h2>Jackson’s bets are widely watched by retail investors. The EMJ Capital founder, who also runs a crypto treasury company, has previously backed Palantir, Carvana, Better Home &amp; Finance, IREN, and BTQ Technologies, among others.<a href="https://stocktwits.com/symbol/DAVE">Dave's shares</a> are down 16.3% year-to-date. On Stocktwits, the retail sentiment for DAVE was ‘bullish’ as of early Monday.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

A trader checking stock market charts. Hedge fund manager Eric Jackson highlighted sharp upside for Dave, Inc. shares. (Picture source: Getty Images)

Cash advances platform Dave is testing a new product that would allow customers to split a purchase into four equal, interest-free installments without using a credit card.

Why Opendoor Bull Eric Jackson Thinks DAVE Stock Could Be Next SEZL

Cash advances platform Dave is testing a new product that would allow customers to split a purchase into four equal, interest-free installments without using a credit card.


Roundhill MEME Stock ETF

Opendoor Technologies Inc

Sezzle Inc.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$DAVE 

These lads guided $17-17.5 a share in EPS for 2026. 

At their growth rate the flush to the low 300s (options related mainly) looks like a buying opportunity to me. 

I added yesterday and then again today.

Chop chop huckleberries $DAVE   Respect to da Doc for not being a bum 🐑 bahhhhlocker.  Pump away.  🍿

$DAVE Looks like it’s coiling for the pre earnings run to previous highs and then it’ll be either sell the news (despite great earnings like usual) or new all time highs and re-rating. Holding my full position.

Feed

News

Sentiment

Earnings

Fundamentals

Info

DAVE Dave Inc

Fundamentals

Latest DAVE News